Summary: If you hold $GGRP (+2.46%) (WisdomTree Global Quality Div Growth), the fund you bought a year ago is not the fund you own today.
Following the March 25, 2026 special rebalance, the ETF has undergone a massive fundamental shift.
1. The "Big Exit": Precision on Outflows 📉
The user-reported "€100M outflow" is backed by the data.
• Pre-Rebalance AUM: ~€300.5 Million (Early March 2026)
• Post-Rebalance AUM:
€213 Million (as of April 1, 2026)
• Total Outflow: Approximately €87.5 Million (~29% of the fund) left in a 3-week window. This suggests institutional investors were not comfortable with the new 30% Tech cap or the move away from historical growth metrics.
2. Impact on "Dividend Growth" Investors ⚠️
Historically, WTEQ investors wanted a mix of dividend income and high-conviction growth. The new rules change the "Growth" part of that equation:
• Forward-Looking Bias: The growth factor is now 50% weighted on analyst earnings forecasts.
• The Risk: Instead of buying companies with a proven track record of growing earnings, the fund is now betting on consensus predictions. This can lead to higher turnover if analysts' "AI hype" doesn't materialize.
• The P/E Penalty (Relevancy Score): The fund now applies a "valuation haircut." If a high-quality stock becomes "too expensive" (high P/E), its weight is automatically cut.
• Impact: This effectively turns WTEQ into a Value fund. You will likely see lower volatility, but you will miss the "parabolic moves" of high-growth tech.
3. Biggest Stock & Sector Movers (March 2026)
The rebalance saw a massive "trimming of the canopy" at the top and a "clean out" at the bottom:
• Apple & Microsoft weights were cut down to ~3.7% and ~3.5% respectively to respect the new 30% sector cap.
• Meta Platforms saw a weight boost, alongside defensive giants like Toyota Motor and AbbVie Inc. which are now top-5 holdings.
• The 50 smallest companies by weight were removed entirely to improve liquidity. This reduced the fund from ~300 to ~250 stocks.
• Health Care (+4.2%) and Consumer Staples (+2.8%) were the biggest beneficiaries of the capital taken away from Tech.
Sector Allocation Shift:
• Technology: 38% ➡️ 30% (Hard Cap)
• Healthcare: 14% ➡️ 18.2%
• Consumer Staples: 10% ➡️
The Verdict: If you are a long-term Dividend Growth investor who wants "Tech-lite" stability, this rebalance is a win. It secures a higher yield (now targeting ~2.2%) and prevents the fund from becoming a "closet NASDAQ index."
However, if you bought $GGRP (+2.46%) for Total Return and aggressive growth, you may find the new "Quality Value" approach too slow for your tastes.
Is anyone concerned that the 50% reliance on analyst forecasts makes the fund too speculative, or do you prefer this forward-looking approach over the old 5-year historical lookback?
